GPCR · Structure Therapeutics Inc.

$47.38 -1.84 (-3.74%) At close · Aug 28

Market Cap

$3.51B

71.31M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-06	2026-06-30
8-K	2026-08-06	—
8-K	2026-06-18	2026-06-17
Investor Event Transcript	2026-06-09	2026-06-30
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-05-07	—
10-Q	2026-05-07	2026-03-31
DEF 14A	2026-04-23	2026-06-17
8-K	2026-04-15	—
8-K	2026-03-16	—
10-K	2026-02-26	2025-12-31
8-K	2026-02-26	—
8-K	2026-01-05	2025-12-30
8-K	2025-12-10	2025-12-09
8-K	2025-12-08	—
8-K	2025-11-06	—
10-Q	2025-11-06	2025-09-30
10-Q	2025-08-06	2025-06-30
8-K	2025-08-06	—
8-K	2025-06-25	2025-06-23
8-K	2025-05-08	—
10-Q	2025-05-08	2025-03-31
DEF 14A	2025-04-24	2025-06-23
10-K	2025-02-27	2024-12-31
8-K	2025-02-27	—
8-K	2024-12-17	—
8-K	2024-11-13	—
10-Q	2024-11-13	2024-09-30
8-K	2024-09-17	2024-09-12
8-K	2024-08-27	2024-08-24
8-K	2024-08-08	—
10-Q	2024-08-08	2024-06-30
8-K	2024-06-27	2024-06-25
8-K	2024-06-03	—
8-K	2024-06-03	—
8-K	2024-05-09	—
10-Q	2024-05-09	2024-03-31
DEF 14A	2024-04-25	2024-06-25
8-K	2024-03-08	—
10-K	2024-03-08	2023-12-31
8-K	2023-12-18	—
10-Q	2023-11-17	2023-09-30
10-Q/A	2023-11-17	2023-06-30
10-Q/A	2023-11-16	2023-06-30
8-K	2023-11-14	2023-11-07
8-K	2023-09-29	—
8-K	2023-09-29	—
8-K	2023-08-10	—
10-Q	2023-08-10	2023-06-30
8-K	2023-08-04	2023-08-03

Showing 1–50 of 57 filings

Key facts CIK 1888886 CUSIP 86366E106 13F (30d) 170 filings 169 filers Visit website Investor relations